ARQT FY 2019 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$195,000

Operating Income

-$43M

Net Income

-$42M

EPS (Diluted)

$-1.10

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$824,000

Balance Sheet

Total Assets

$107M

Total Liabilities

$6M

Stockholders' Equity

$101M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$195,000	$0	—
Operating Income	-$43M	-$20M	-118.6%
Net Income	-$42M	-$19M	-118.1%